AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Parovis-CR 37.5 Tablet

Prescription Icon
Prescription Required

Marketer

Adivis Pharma Pvt Ltd

Salt Composition

Paroxetine (37.5mg)

Overview Parovis-CR 37.5 Tablet

Sertraline CR 37.5mg tablets are an antidepressant medication classified as a selective serotonin reuptake inhibitor (SSRI). Prescribed extensively for depression and anxiety disorders such as obsessive-compulsive disorder and panic attacks, these tablets help many patients recover by improving mood and reducing anxiety and tension. Administration is independent of food intake. Dosage and frequency are determined by your physician to optimize symptom management, often starting with a low dose gradually increased. Never alter your dosage or cease treatment without consulting your doctor; doing so could worsen your condition or trigger unpleasant withdrawal symptoms (including anxiety, restlessness, rapid heartbeat, dizziness, sleep problems, etc.). For maximum effectiveness, take this medication consistently at the same time daily; morning administration may be recommended if sleep disturbances occur. Significant improvement may take several weeks. Report lack of progress after four weeks of treatment. Common side effects include nausea, tiredness, dry mouth, appetite changes, increased perspiration, dizziness, nervousness, tremors, insomnia, and constipation. Reduced libido, delayed ejaculation, and erectile dysfunction are also possible. Immediately report any sudden mood deterioration or suicidal thoughts. Before starting treatment, disclose any history of epilepsy, diabetes, liver or kidney disease, heart conditions, or glaucoma as these may influence treatment. This is crucial for pregnant or breastfeeding individuals as well. Certain medications, particularly other antidepressants and MAO inhibitors, may interact; inform your doctor of all medications you are currently taking to ensure your safety.

Uses of Parovis-CR 37.5 Tablet

Managing depressive symptoms | Addressing panic attacks and disorder | Anxiety disorder intervention

Major Benefits of Parovis-CR 37.5 Tablet:

Follow your physician's instructions or refer to the product label for proper administration. Parovis-CR 37.5 Tablets can be ingested with or without food; however, consistent daily timing is recommended.

Common Side effects of Parovis-CR 37.5 Tablet:

  • Nausea
  • Fatigue
  • Dryness in mouth
  • Loss of appetite
  • Increased sweating
  • Dizziness
  • Nervousness
  • Tremors
  • Low sexual desire
  • Insomnia (difficulty in sleeping)
  • Confusion
  • Constipation
  • Erectile dysfunction
  • Delayed ejaculation
  • Decreased libido

How to use Parovis-CR 37.5 Tablet:

Follow your physician's instructions or consult the product information leaflet for usage guidelines. The Parovis-CR 37.5 Tablet can be administered with or without food; however, consistent daily timing is recommended.

How Parovis-CR 37.5 Tablet works:

Deplin 37.5mg tablets, a selective serotonin reuptake inhibitor (SSRI), function by elevating serotonin concentrations in the brain. This neurotransmitter modulation alleviates depressive symptoms, both emotional and somatic, and offers relief from panic disorder, anxiety, and obsessive-compulsive disorder.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Parovis-CR 37.5 Tablet with alcohol is not advised due to safety concerns.

PregnancyPregnancyUNSAFE

The use of Parovis-CR 37.5 Tablet is strongly contraindicated during pregnancy. Pregnant individuals should consult their physician, as research in both animal models and pregnant women has revealed substantial adverse effects on fetal development.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Parovis-CR 37.5 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Parovis-CR 37.5 Tablet may cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects are experienced.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Parovis-CR 37.5 mg tablets. Dosage modification may be necessary; physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Parovis-CR 37.5mg tablets. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Parovis-CR 37.5 Tablet :

Should you forget a Parovis-CR 37.5 Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Parovis-CR 37.5 Tablet

LabelValue
Type of Compound Piperidine-based phenyl derivative
Addictive None.
Type of Medication Central and peripheral nervous system
Mechanism of Action Serotonin-specific reuptake inhibitors

FAQs on Parovis-CR 37.5 Tablet

Noticeable symptom relief might begin within one to two weeks of commencing treatment. However, if you experience no improvement, continue taking the medication and schedule an appointment with your physician. Complete therapeutic effects may become apparent after four to six weeks.
Discontinuing Parovis-CR 37.5 Tablet without medical advice is strongly discouraged. While an initial increase in symptoms is possible, therapeutic effects typically become evident within one to two weeks. However, if symptoms remain or worsen after this period, seek immediate medical attention.
Parovis-CR 37.5 Tablet use may impact sexual function. Reduced libido and difficulties achieving orgasm can occur in both sexes. Men may also encounter irregularities in erectile function and ejaculation.
Individuals younger than 18 should not take Parovis-CR 37.5 mg tablets. This is because adolescents and children may experience a heightened risk of adverse reactions including suicidal ideation, hostility, defiant behavior, and irritability. Should your child's physician have prescribed Parovis-CR 37.5 mg tablets and concerns about these potential side effects arise, consult with the prescribing physician.
Concurrent use of Parovis-CR 37.5 Tablet and tamoxifen is contraindicated. While Parovis-CR 37.5 Tablet can alleviate tamoxifen-induced hot flashes, its concomitant administration diminishes tamoxifen's efficacy and potentially increases breast cancer relapse risk.
Diabetic patients should exercise caution when using Parovis-CR 37.5 Tablets, as this medication can influence blood glucose control. Consequently, your insulin or other diabetes medication dosage may require modification. Consult your physician for guidance and monitor your blood sugar diligently.
Parovis-CR 37.5 Tablet
207
MRP 252
17% off